20
Chengdu Shengnuo Biopharm Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is EPTIFIBATIDE, with a corresponding US DMF Number 27651.
Remarkably, this DMF maintains an Active status since its submission on December 19, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on January 17, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II